Showing results (11-20 of 73) with videos related to
Sort By:
Pageof 8
Human Psychopharmacology|July 15, 2004
Clomipramine, fluoxetine and CYP2D6 metabolic capacity in depressed patientsP Vandel, E Haffen, S Nezelof, et al.L'Encephale|July 6, 2013
[Sexual dysfunction and depression: Validity of a French version of the ASEX scale]M Briki, E Haffen, J Monnin, et al.Therapie|September 1, 2000
Drug extrapyramidal side-effects or not: is there a dextromethorphan phenotype difference?P Vandel, E Haffen, S Vandel, et al.Pharmacopsychiatry|December 22, 1999
Citalopram: an interaction study with clomipramine in a patient heterozygous for CYP2D6 genotypeE Haffen, P Vandel, F Broly, et al.L'Encephale|May 1, 1996
[Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration]B Bonin, G Bertschy, P Baumann, et al.L'Encephale|June 1, 1997
[Indications for electroconvulsive therapy]J Boiteux, L Roubaud, N Gandelet, et al.Therapie|January 1, 1995
[Undesirable effects of drugs. Epidemiologic study at a psychiatric service of a university hospital]P Vandel, P Bizouard, S Vandel, et al.European Journal of Clinical Pharmacology|January 19, 2000
Drug extrapyramidal side effects. CYP2D6 genotypes and phenotypesP Vandel, E Haffen, S Vandel, et al.Pageof 8